Inventor · disambiguated record
Yun Ju Jeong
Also filed as: JEONG YUN JU
13 granted patents·4 pending applications·54 citations·filing 2012–2021
89Inventor score
Top patents by PatentIndex Score
17 records- 0187US9931400B2Method of combination therapy for prevention or treatment of c-Met or angiogenesis factor induced diseasesSAMSUNG ELECTRONICS CO LTD·Filed 2013·Granted Apr 3, 2018·5 cites·10 claims
- 0287US9213031B2Use of Cbl as biomarker for identifying subject suitable for treatment with anti-c-Met antibodySAMSUNG ELECTRONICS CO LTD·Filed 2013·Granted Dec 15, 2015·7 cites·12 claims
- 0387US8501917B2Anti c-Met antibody and uses thereofSAMSUNG ELECTRONICS CO LTD·Filed 2012·Granted Aug 6, 2013·6 cites·22 claims
- 0486US9650443B2Fusion protein comprising anti-c-Met antibody and VEGF-binding fragmentSAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted May 16, 2017·9 cites·17 claims
- 0585US9717715B2Method of combination therapy using an anti-C-Met antibodySAMSUNG ELECTRONICS CO LTD·Filed 2013·Granted Aug 1, 2017·5 cites·6 claims
- 0684US9233155B2Method of treating solid cancers using anti-c-Met antibody and sorafenib combination therapySAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Jan 12, 2016·4 cites·13 claims
- 0780US9556275B2Combination therapy using anti-C-met antibody and anti-ang-2 antibodySAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Jan 31, 2017·7 cites·6 claims
- 0880US9192666B2Method of treating cancer using anti-c-Met antibody and FGFR inhibitor combination therapySAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Nov 24, 2015·4 cites·15 claims
- 0978US9572878B2Method of combination therapy using an EGFR antagonist and anti-c-Met antibodySAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Feb 21, 2017·5 cites·13 claims
- 1074US9517266B2Liquid formulation containing a protein drugSAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Dec 13, 2016·2 cites·13 claims
- 1166US9889206B2C-Met targeting compound-bioactive material conjugate and use thereofSAMSUNG ELECTRONICS CO LTD·Filed 2014·Granted Feb 13, 2018·0 cites·8 claims
- 1262US10792371B2c-Met targeting compound-bioactive material conjugate and use thereofSAMSUNG ELECTRONICS CO LTD·Filed 2018·Granted Oct 6, 2020·0 cites·16 claims
- 1361US2021269533A1Anti-c-met antibody and uses thereofSAMSUNG ELECTRONICS CO LTD·Filed 2021·Application pending·0 cites
- 1456US11135254B2Bifidobacterium longum RAPO strain for alleviating, treating or preventing rheumatoid arthritis and composition containing the sameBIFIDO CO LTD·Filed 2019·Granted Oct 5, 2021·0 cites·3 claims
- 1553US2014154251A1Anti c-met antibody and uses thereofSAMSUNG ELECTRONICS CO LTD·Filed 2013·Application pending·0 cites
- 1652US2023192893A1Human genome-derived polynucleotide and method for producing polypeptide of interest using sameSAMSUNG BIOEPIS CO LTD·Filed 2020·Application pending·0 cites
- 1739US2013089542A1Anti c-met antibody and uses thereofSAMSUNG ELECTRONICS CO LTD·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →